{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:26Z","timestamp":1790691386395,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13256-016-1147-5","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T13:57:16Z","timestamp":1484315836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report"],"prefix":"10.1186","volume":"11","author":[{"given":"Ferdinando","family":"Ceravolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Grisolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sestito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Falvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Moricca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Concolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,20]]},"reference":[{"key":"1147_CR1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1007\/s00415-015-7889-y","volume":"262","author":"M Synofzik","year":"2015","unstructured":"Synofzik M, Harmuth F, Stampfer M, M\u00fcller Vom Hagen J, Sch\u00f6ls L, Bauer P. NPC1 is enriched in unexplained early onset ataxia: a targeted high-throughput screening. J Neurol. 2015;262:2557\u201363.","journal-title":"J Neurol"},{"key":"1147_CR2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249\u201354.","journal-title":"JAMA"},{"key":"1147_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","volume":"105","author":"BJ Poorthuis","year":"1999","unstructured":"Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet. 1999;105:151\u20136.","journal-title":"Hum Genet"},{"key":"1147_CR4","doi-asserted-by":"crossref","first-page":"24367","DOI":"10.1074\/jbc.M002184200","volume":"275","author":"JP Davies","year":"2000","unstructured":"Davies JP, Ioannou YA. Topological analysis of Niemann-Pick C1 protein reveals that the membrane orientation of the putative sterol-sensing domain is identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and sterol regulatory element binding protein cleavage-activating protein. J Biol Chem. 2000;275:24367\u201374.","journal-title":"J Biol Chem"},{"issue":"Suppl 326","key":"1147_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1986.tb14936.x","volume":"75","author":"A Erikson","year":"1986","unstructured":"Erikson A. Gaucher disease-Norrbottnian type (III): neuropaediatric and neurobiological aspects of clinical patterns and treatment. Acta Paediatr Scand Suppl. 1986;75 Suppl 326:1\u201342.","journal-title":"Acta Paediatr Scand Suppl"},{"key":"1147_CR6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","volume":"33","author":"A Tylki-Szymanska","year":"2010","unstructured":"Tylki-Szymanska A, Vellodi A, El-Beshlawy A, Cole JA, Kolodny E. Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry. J Inherit Metab Dis. 2010;33:339\u201346.","journal-title":"J Inherit Metab Dis"},{"key":"1147_CR7","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","volume":"160","author":"J Charrow","year":"2000","unstructured":"Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, et al. The Gaucher Registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med. 2000;160:2835\u201343.","journal-title":"Arch Intern Med"},{"key":"1147_CR8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.mop.0000172702.33128.19","volume":"17","author":"GA Grabowski","year":"2005","unstructured":"Grabowski GA. Recent clinical progress in Gaucher disease. Curr Opin Pediatr. 2005;17:519\u201324.","journal-title":"Curr Opin Pediatr"},{"key":"1147_CR9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0950-3536(97)80035-2","volume":"10","author":"A Erikson","year":"1997","unstructured":"Erikson A, Bembi B, Schiffmann R. Neuronopathic forms of Gaucher\u2019s disease. Baillieres Clin Haematol. 1997;10:711\u201323.","journal-title":"Baillieres Clin Haematol"},{"key":"1147_CR10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10545-009-1164-2","volume":"32","author":"A Vellodi","year":"2009","unstructured":"Vellodi A, Tylki-Szymanska A, Davies EH, Kolodny E, Bembi B, Collin-Histed T, et al. Management of neuronopathic Gaucher disease: revised recommendations. J Inherit Metab Dis. 2009;32:660\u20134.","journal-title":"J Inherit Metab Dis"},{"key":"1147_CR11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1212\/WNL.43.10.1993","volume":"43","author":"MC Patterson","year":"1993","unstructured":"Patterson MC, Horowitz M, Abel RB, Currie JN, Yu KT, Kaneski C, et al. Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher\u2019s disease. Neurology. 1993;43:1993\u20137.","journal-title":"Neurology"},{"key":"1147_CR12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1445-5994.2006.01153.x","volume":"36","author":"DR Williams","year":"2006","unstructured":"Williams DR. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J. 2006;36:652\u201360.","journal-title":"Intern Med J"},{"key":"1147_CR13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1359\/jbmr.061004","volume":"22","author":"RJ Wenstrup","year":"2007","unstructured":"Wenstrup RJ, Kacena KA, Kaplan P, Pastores GM, Prakash-Cheng A, Zimran A, et al. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease. J Bone Miner Res. 2007;22:119\u201326.","journal-title":"J Bone Miner Res"},{"key":"1147_CR14","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","volume":"269","author":"FM Platt","year":"1994","unstructured":"Platt FM, Neises GR, Dwek RA, Butters TD. N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J Biol Chem. 1994;269:8362\u20135.","journal-title":"J Biol Chem"},{"key":"1147_CR15","unstructured":"European Medicines Agency. Zavesca\u00ae (miglustat). http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=search.jsp&q=zavesca&btnG=Search&mid= . Accessed 26 Nov 2016."},{"key":"1147_CR16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2014.07.022","volume":"113","author":"A Sechi","year":"2014","unstructured":"Sechi A, Deroma L, Dardis A, Ciana G, Bertin N, Concolino D, et al. Long term effects of enzyme replacement therapy in an Italian cohort of type 3 Gaucher patients. Mol Genet Metab. 2014;113:213\u20138.","journal-title":"Mol Genet Metab"},{"key":"1147_CR17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","volume":"29","author":"JM Aerts","year":"2006","unstructured":"Aerts JM, Hollak CE, Boot RG, Groener JE, Maas M. Substrate reduction therapy of glycosphingolipid storage disorders. J Inherit Metab Dis. 2006;29:449\u201356.","journal-title":"J Inherit Metab Dis"},{"key":"1147_CR18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/00498250601094543","volume":"37","author":"A Treiber","year":"2007","unstructured":"Treiber A, Morand O, Clozel M. The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat. Xenobiotica. 2007;37:298\u2013314.","journal-title":"Xenobiotica"},{"key":"1147_CR19","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1528-1167.2007.01074.x","volume":"48","author":"JL Capablo","year":"2007","unstructured":"Capablo JL, Franco R, de Cabezon AS, Alfonso P, Pocovi M, Giraldo P. Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase\/miglustat combination. Epilepsia. 2007;48:1406\u20138.","journal-title":"Epilepsia"},{"key":"1147_CR20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10545-008-0873-2","volume":"31","author":"J Cox-Brinkman","year":"2009","unstructured":"Cox-Brinkman J, van Breemen MJ, van Maldegem BT, Bour L, Donker WE, Hollak CEM, et al. Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type III. In J Inherit Metab Dis. 2009;31:745\u201352.","journal-title":"In J Inherit Metab Dis"},{"key":"1147_CR21","doi-asserted-by":"crossref","first-page":"358534","DOI":"10.1155\/2010\/358534","volume":"2010","author":"A Accardo","year":"2010","unstructured":"Accardo A, Pensiero S, Ciana G, Parentin F, Bembi B. Eye movement impairment recovery in a Gaucher patient treated with miglustat. Neurol Res Int. 2010;2010:358534.","journal-title":"Neurol Res Int"},{"key":"1147_CR22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","volume":"29","author":"KS Hruska","year":"2008","unstructured":"Hruska KS, LaMarca ME, Scott CR, Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat. 2008;29:567\u201383.","journal-title":"Hum Mutat"},{"issue":"1","key":"1147_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00125817-200001000-00059","volume":"2","author":"CR Scott","year":"2000","unstructured":"Scott CR, Pastores G, Andersson H, Charrow J, Kaplan P, Kolodny E, et al. The clinical expression of Gaucher disease correlates with genotype: data from 570 patients [abstract 10]. Genet Med. 2000;2(1):65.","journal-title":"Genet Med"},{"key":"1147_CR24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s004399900076","volume":"105","author":"H Ida","year":"1999","unstructured":"Ida H, Rennert OM, Iwasawa K, Kobayashi M, Eto Y. Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation. Hum Genet. 1999;105:120\u20136.","journal-title":"Hum Genet"},{"key":"1147_CR25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2007.12.023","volume":"153","author":"O Goker-Alpan","year":"2008","unstructured":"Goker-Alpan O, Wiggs EA, Eblan MJ, Benko W, Ziegler SG, Sidransky E, et al. Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease. J Pediatr. 2008;153:89\u201394.","journal-title":"J Pediatr"},{"key":"1147_CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","volume":"64","author":"R Schiffmann","year":"2008","unstructured":"Schiffmann R, Fitzgibbon EJ, Harris C, DeVile C, Davies EH, Abel L, et al. Randomized, controlled trial of miglustat in Gaucher\u2019s disease type 3. Ann Neurol. 2008;64:514\u201322.","journal-title":"Ann Neurol"},{"key":"1147_CR27","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10545-008-0873-2","volume":"31","author":"J Cox-Brinkman","year":"2008","unstructured":"Cox-Brinkman J, van Breemen MJ, van Maldegem BT, Bour L, Donker WE, Hollak CE, et al. Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type III. J Inherit Metab Dis. 2008;31:745\u201352.","journal-title":"J Inherit Metab Dis"},{"key":"1147_CR28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10545-011-9368-7","volume":"34","author":"N Belmatoug","year":"2011","unstructured":"Belmatoug N, Burlina A, Giraldo P, Hendriksz CJ, Kuter DJ, Mengel E, et al. Gastrointestinal disturbances and their management in miglustat-treated patients. J Inherit Metab Dis. 2011;34:991\u20131001.","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 3","key":"1147_CR29","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1007\/s10545-010-9193-4","volume":"33","author":"H Champion","year":"2010","unstructured":"Champion H, Ramaswami U, Imrie J, Lachmann RH, Gallagher J, Cox TM, et al. Dietary modifications in patients receiving miglustat. J Inherit Metab Dis. 2010;33 Suppl 3:S379\u201383.","journal-title":"J Inherit Metab Dis"},{"key":"1147_CR30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0755-4982(04)98639-3","volume":"33","author":"P D\u00e9chelotte","year":"2004","unstructured":"D\u00e9chelotte P. Type 1 Gaucher\u2019s disease in the adult: nutritional management during initiation of treatment with miglustat [in French]. Presse Med. 2004;33:494\u20136.","journal-title":"Presse Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-1147-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T17:01:54Z","timestamp":1658422914000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-016-1147-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,20]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1186\/s13256-016-1147-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,20]]},"article-number":"19"}}